New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 15, 2011, Pages 4498-4502

  Barea, Carlos ^a   Pabón, Adriana ^b   Castillo, Denis ^c   Zimic, Mirko ^c   Quiliano, Miguel ^c   Galiano, Silvia ^a   Pérez Silanes, Silvia ^a   Monge, Antonio ^a   Deharo, Eric ^d,e   Aldana, Ignacio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Peru)

Author keywords

Leishmaniasis; Malaria; N Oxides; Quinoxaline

Indexed keywords

3 AMINO 1,4 DI N OXIDE QUINOXALINE 2 CARBONITRILE DERIVATIVE; ANTILEISHMANIAL AGENT; ANTIMALARIAL AGENT; CHLOROQUINE; SALICYLAMIDE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; INTESTINE ABSORPTION; LEISHMANIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; LEISHMANIA MEXICANA; MACROPHAGES; MICE; PLASMODIUM FALCIPARUM; QUINOXALINES; SALICYLAMIDES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; TRYPANOCIDAL AGENTS;

LEISHMANIA AMAZONENSIS; PLASMODIUM FALCIPARUM;

EID: 79960341464     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.05.125     Document Type: Article

References (21)

1. E. Vicente, S. Charnaud, E. Bongard, R. Villar, A. Burguete, B. Solano, S. Ancizu, S. Perez-Silanes, I. Aldana, L. Vivas, and A. Monge Molecules 13 2008 69
2. C. Biot, and K. Chibale Infect. Disord. Drug Targets 2 2006 173
3. WHO: http://www.who.int/malaria/world-malaria-report-2010/en/index.html.
4. WHO: http://www.who.int/leishmaniasis/en/. Accessed 27 March, 2011.
5. L. Kedzierski, A. Sakthianandeswaren, J.M. Curtis, P.C. Andrews, P.C. Junk, and K. Kedzierska Curr. Med. Chem. 16 2009 599
6. A. Carta, P. Corona, and M. Loriga Curr. Med. Chem. 12 2005 2259
7. A. Monge, J.A. Palop, A. Piñol, F.J. Martínez-Crespo, S. Narro, M. González, Y. Sáinz, and A.J. López de Ceráin Heterocycl. Chem. 31 1994 1135
8. A. Burguete, Y. Estevez, D. Castillo, G. González, R. Villar, B. Solano, E. Vicente, S. Pérez-Silanes, I. Aldana, A. Monge, M. Sauvain, and E. Deharo Memorias do Oswaldo Cruz 103 2008 778
9. Y. Estevez, M. Quiliano, A. Burguete, M. Zimic, E. Málaga, M. Verástegui, S. Pérez-Silanes, I. Aldana, A. Monge, D. Castillo, and E. Deharo Exp. Parasitol. 127 2011 745
10. S. Ancizu, E. Moreno, E. Torres, A. Burguete, S. Perez-Silanes, D. Benitez, R. Villar, B. Solano, A. Marin, I. Aldana, H. Cerecetto, M. Gonzalez, and A. Monge Molecules 14 2009 2256
11. M.A. Ortega, Y. Sainz, M.E. Montoya, A. Jaso, B. Zarranz, I. Aldana, and A. Monge Arzneim.-Forsch. 52 2002 113
12. M. González, and H. Cerecetto Springer 10 2007 265
13. K. Ley, and F. Seng Synthesis 1975 415
14. M.A. Dea-Ayuela, E. Castillo, M. González-Álvarez, C. Vega, M. Rolón, F. Bolás-Fernández, J. Borrás, and M.E. González-Rosende Bioorg. Med. Chem. 17 2009 7449
15. P. Ertl, B. Rohde, and P. Selzer J. Med. Chem. 43 2000 3714
16. Y.H. Zhao, M.H. Abraham, J. Le, A. Hersey, C.N. Luscombe, G. Beck, B. Sherborne, and I. Cooper Pharm. Res. 19 2002 1446
17. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Adv. Drug Delivery Rev. 46 2001 3
18. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple J. Med. Chem. 45 2002 2615
19. L.P.S. De Carvalho, G. Lin, X. Jiang, and C. Nathan J. Med. Chem. 52 2009 5789
20. L.F. Gordon J. Pharm. Sci. 69 1980 1109
21. T. Cheeseright, M. Mackey, S. Rose, and J.G. Vinter J. Chem. Inf. Model. 46 2006 665